BCG vaccine effect against tuberculosis infection and disease

October 12, 2005

BCG vaccination can protect children from tuberculosis (TB) infection as well as active TB disease, according to a study published online today (Thursday October 13, 2005) by THE LANCET.

There are about 10 million cases of TB globally each year and 1 in 3 people are infected with the TB bacterium. BCG is the most widely used vaccine worldwide, but its mechanism of protection is poorly understood. It is thought to prevent progression of infection to active TB but whether it protects against the acquisition of infection itself has not been investigated in humans. The effect of BCG vaccine has been difficult to ascertain because, until recently, the century-old tuberculin skin-prick test (TST) was the only method for detecting infection. However, TST cannot reliably distinguish between TB infection and BCG vaccination. In this study researchers used the more accurate T-cell based blood test called the ELISpot and TST to assess infection.

Ajit Lalvani (Wellcome Trust Senior Clinical Research Fellow, University of Oxford, UK) and colleagues investigated risk factors for TB infection in 979 children from Istanbul, Turkey. All children taking part shared a household with at least one adult with TB. 770 of the children had a BCG scar. The researchers found that the absence of a BCG scar was a strong, independent risk factor for infection in TB-exposed children, while the presence of a BCG scar was associated with a 24% reduction in risk of being infected. The authors state that this finding furthers our understanding of the biology of TB transmission and has important implications for the development of new TB vaccines.

Dr Lalvani states: "Contrary to prevailing theory that BCG vaccination protects only against tuberculosis disease, our results suggest that the vaccine also protects against tuberculosis infection...Our findings show that children can be protected against TB infection by vaccination and this opens a new door for the development of new, improved vaccines." (Quote by e-mail; does not appear in published paper)
See also accompanying comment.

Contact: Dr Ajit Lalvani, Nuffield Department of Clinical Medicine, University of Oxford, Level 7,John Radcliffe Hospital, Headley Way, OXFORD, OX3 9DU, UK. T) +44 (0) 7767 700 873


Related Tuberculosis Articles from Brightsurf:

Scientists find new way to kill tuberculosis
Scientists have discovered a new way of killing the bacteria that cause tuberculosis (TB), using a toxin produced by the germ itself.

Blocking the iron transport could stop tuberculosis
The bacteria that cause tuberculosis need iron to survive. Researchers at the University of Zurich have now solved the first detailed structure of the transport protein responsible for the iron supply.

Tuberculosis: New insights into the pathogen
Researchers at the University of W├╝rzburg and the Spanish Cancer Research Centre have gained new insights into the pathogen that causes tuberculosis.

Unmasking the hidden burden of tuberculosis in Mozambique
The real burden of tuberculosis is probably higher than estimated, according to a study on samples from autopsies performed in a Mozambican hospital.

HIV/tuberculosis co-infection: Tunneling towards better diagnosis
1.2 million people in the world are co-infected by the bacteria which causes tuberculosis and AIDS.

Reducing the burden of tuberculosis treatment
A research team led by MIT has developed a device that can lodge in the stomach and deliver antibiotics to treat tuberculosis, which they hope will make it easier to cure more patients and reduce health care costs.

Tuberculosis: Commandeering a bacterial 'suicide' mechanism
The bacteria responsible for tuberculosis can be killed by a toxin they produce unless it is neutralized by an antidote protein.

A copper bullet for tuberculosis
Tuberculosis is a sneaky disease, and the number one cause of death from infectious disease worldwide.

How damaging immune cells develop during tuberculosis
Insights into how harmful white blood cells form during tuberculosis infection point to novel targets for pharmacological interventions, according to a study published in the open-access journal PLOS Pathogens by Valentina Guerrini and Maria Laura Gennaro of Rutgers New Jersey Medical School, and colleagues.

How many people die from tuberculosis every year?
The estimates for global tuberculosis deaths by the World Health Organisation (WHO) and the Institute for Health Metrics and Evaluation (IHME) differ considerably for a dozen countries, according to a study led by ISGlobal.

Read More: Tuberculosis News and Tuberculosis Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to